What is REGN's current stock price?

As of now, REGN is trading at $740.70, with a daily change of +1.97%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

REGN Stock Analysis & IQ Rating | Regeneron Pharmaceuticals

REGN

Regeneron Pharma

$740.70

+$14.49 | +1.97%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$790.98

MKT CAP

$77.81B

52W Low

$476.49

VOL

$598.69K

P/E Ratio

17.72

AVG VOL

$1.10M

RSI

59.22

TREND

Uptrend

REGN Stock IQ

Login to see Regeneron Pharma (REGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

REGN Target Price

Login to display

Strengths

REGN Rewards

Earnings are forecast to grow

REGN Rewards

Upgraded on attractively valued

REGN Rewards

Trading below its fair value

REGN Rewards

Outperform the market

Technical Indicators

REGN Technical Indicators

5+ Days Down

REGN Price Performance

$693.86 (+6.75%)

$598.71 (+23.72%)

$572.39 (+29.40%)

$716.68 (+3.35%)

1year

6month

3month

1month

REGN Risk Level

REGN has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

REGN Analysts Opinion

REGN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

REGN Analysts Opinion

REGN Analysts opinion is positive and also has improved from the past 3 months

REGN Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

92%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

67%

95%

REGN Street Sentiment

REGN Street Sentiment is extremely bullish and have positive views on the near-term outlook

REGN Performance Sentiment

Sentiments overview associated with REGN events and the stock performance.

92%

0%

Positive

Negative

35 out of 38
events present

0 out of 38
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$703.26

Resistance
Price

$638.77

Current Price Range

$787.32

Show methods +

Linked to REGN

IQ

Close Price

Change

NVS

4.27

132.48

+0.97%

SNY

4.02

48.74

+0.97%

MRK

4.03

98.66

+1.09%

AZN

4.31

90.48

-1.13%

OPK

2.40

1.36

-0.73%

REGN Latest Analysis +

Regeneron Pharmaceuticals Inc. (REGN) Discusses Lynozyfic Development Strategy and Pipeline Opportunities in Multiple Myeloma Transcript.

Wed Dec 10, 2025

$726.21 | +4.86%

Potential

Regenerons (REGN) Recovery and Dupixent Strength Support BMOs Outperform Rating. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is included among the 14 Best US Stocks to Buy for Long Term. On December 4 BMO Capital analyst Evan Seigerman boosted the firms price target on Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) to $850 from $725 and maintained an Outperform rating on the stock. The analyst noted that the stock has surged [….]

Mon Dec 8, 2025

$703.26 | -2.10%

Activity

Momentum

Potential

Benjamin Graham Detailed Fundamental Analysis - REGN. Below is Valideas guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow REGN rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that hav

Mon Dec 8, 2025

$703.26 | -2.10%

Potential

Regeneron Reports Promising Phase 1/2 Data Of Lynozyfic In Newly Diagnosed Multiple Myeloma . (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging results from the Phase 1/2 LINKER-MM4 trial evaluating Lynozyfic (linvoseltamab) in adults with newly diagnosed multiple myeloma (NDMM) both transplant-eligible and transplant-ineligible. The findings were s

Mon Dec 8, 2025

$703.26 | -2.10%

Activity

Benjamin Graham Detailed Fundamental Analysis - REGN. Below is Valideas guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow REGN rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that hav

Fri Dec 5, 2025

$718.36 | -0.61%

Potential

Market Whales and Their Recent Bets on REGN Options. Financial giants have made a conspicuous bearish move on Regeneron Pharmaceuticals. Our analysis of options history for Regeneron Pharmaceuticals (NASDAQ:) revealed 12 unusual trades.Delving into the details we found 33% of traders were ish while 50% showed bearish tendencies. Out of all the trades we spotted 7 were puts with a value of $790722 and 5 were calls valued at $142680.After evaluating the trading volumes and Open Interest it'.s

Thu Dec 4, 2025

$722.80 | -0.12%

Momentum

Jim Cramer on Regeneron: Theyre Doing a Lot of Good Stuff I Lost Sight of It I Shouldnt Have. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the stocks Jim Cramer was recently asked about. A caller asked if the stock up 54% from its summer lows can continue its momentum. Heres what Mad Moneys host had to say in response: Yes down 30 today Well its a $750 stock. Now let me just tell [….]

Thu Dec 4, 2025

$722.80 | -0.12%

Momentum

REGN Factor-Based Stock Analysis - Benjamin Graham. Below is Valideas guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow REGN rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that hav

Wed Dec 3, 2025

$723.67 | -2.47%

Potential

Morgan Stanley downgrades Regeneron as rebound leaves less room for upside.

Wed Dec 3, 2025

$723.67 | -2.47%

Potential

Regeneron Pharmaceuticals Inc. (REGN) Presents at Evercore 8th Annual Healthcare Conference Transcript.

Tue Dec 2, 2025

$742.00 | -1.08%

Activity

FAQ About REGN Stock Insights

What is REGN current stock price?

What are REGN stock strengths?

What is REGN Risk Level?

What is REGN market cap and volume?

What is REGN current Stock IQ?

Should I buy REGN stock right now?

Is REGN a Strong Buy right now?

What does a 'Strong Buy' rating mean for REGN?

What does a 'Strong Sell' rating mean for REGN?

What factors influence REGN's Stock IQ?

Explore our REGN Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored REGN Stock Strategies
Effective Risk Management

FIND US ON

Receive our REGN Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

REGN

Regeneron Pharma

Current Price

$740.70

+$14.49 | +1.97%

52W High

$790.98

MKT CAP

$77.81B

52W Low

$476.49

VOL

$598.69K

P/E Ratio

17.72

AVG VOL

$1.10M

RSI

59.22

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

REGN Rewards

Earnings are forecast to grow

REGN Rewards

Upgraded on attractively valued

REGN Rewards

Trading below its fair value

REGN Rewards

Outperform the market

Technical Indicators

REGN Technical Indicators

5+ Days Down

Linked to REGN

Symbol

IQ

Close

Change

NVS

4.27

132.48

+0.97%

SNY

4.02

48.74

+0.97%

MRK

4.03

98.66

+1.09%

AZN

4.31

90.48

-1.13%

OPK

2.40

1.36

-0.73%

REGN Price Performance

$693.86 (+6.75%)

$598.71 (+23.72%)

$572.39 (+29.40%)

$716.68 (+3.35%)

1year

6month

3month

1month

REGN Analysts Opinion

REGN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

REGN Analysts Opinion

REGN Analysts opinion is positive and also has improved from the past 3 months

REGN Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

92%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

67%

95%

REGN Street Sentiment

REGN Street Sentiment is extremely bullish and have positive views on the near-term outlook

REGN Risk Level

REGN has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

REGN Performance Sentiment

Sentiments overview associated with REGN events and the stock performance.

92%

0%

Positive

Negative

35 out of 38
events present

0 out of 38
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$703.26

Resistance
Price

$638.77

Current Price Range

$787.32

Show methods +

REGN Stock IQ

Login to unlock Regeneron Pharma (REGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

REGN Latest Analysis

Regeneron Pharmaceuticals Inc. (REGN) Discusses Lynozyfic Development Strategy and Pipeline Opportunities in Multiple Myeloma Transcript.

Wed Dec 10, 2025

$726.21 | +4.86%

Potential

Regenerons (REGN) Recovery and Dupixent Strength Support BMOs Outperform Rating. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is included among the 14 Best US Stocks to Buy for Long Term. On December 4 BMO Capital analyst Evan Seigerman boosted the firms price target on Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) to $850 from $725 and maintained an Outperform rating on the stock. The analyst noted that the stock has surged [….]

Mon Dec 8, 2025

$703.26 | -2.10%

Activity

Momentum

Potential

Benjamin Graham Detailed Fundamental Analysis - REGN. Below is Valideas guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow REGN rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that hav

Mon Dec 8, 2025

$703.26 | -2.10%

Potential

Regeneron Reports Promising Phase 1/2 Data Of Lynozyfic In Newly Diagnosed Multiple Myeloma . (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging results from the Phase 1/2 LINKER-MM4 trial evaluating Lynozyfic (linvoseltamab) in adults with newly diagnosed multiple myeloma (NDMM) both transplant-eligible and transplant-ineligible. The findings were s

Mon Dec 8, 2025

$703.26 | -2.10%

Activity

Benjamin Graham Detailed Fundamental Analysis - REGN. Below is Valideas guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow REGN rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that hav

Fri Dec 5, 2025

$718.36 | -0.61%

Potential

Market Whales and Their Recent Bets on REGN Options. Financial giants have made a conspicuous bearish move on Regeneron Pharmaceuticals. Our analysis of options history for Regeneron Pharmaceuticals (NASDAQ:) revealed 12 unusual trades.Delving into the details we found 33% of traders were ish while 50% showed bearish tendencies. Out of all the trades we spotted 7 were puts with a value of $790722 and 5 were calls valued at $142680.After evaluating the trading volumes and Open Interest it'.s

Thu Dec 4, 2025

$722.80 | -0.12%

Momentum

Jim Cramer on Regeneron: Theyre Doing a Lot of Good Stuff I Lost Sight of It I Shouldnt Have. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the stocks Jim Cramer was recently asked about. A caller asked if the stock up 54% from its summer lows can continue its momentum. Heres what Mad Moneys host had to say in response: Yes down 30 today Well its a $750 stock. Now let me just tell [….]

Thu Dec 4, 2025

$722.80 | -0.12%

Momentum

REGN Factor-Based Stock Analysis - Benjamin Graham. Below is Valideas guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow REGN rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that hav

Wed Dec 3, 2025

$723.67 | -2.47%

Potential

Morgan Stanley downgrades Regeneron as rebound leaves less room for upside.

Wed Dec 3, 2025

$723.67 | -2.47%

Potential

Regeneron Pharmaceuticals Inc. (REGN) Presents at Evercore 8th Annual Healthcare Conference Transcript.

Tue Dec 2, 2025

$742.00 | -1.08%

Activity

Discover REGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of REGN. We're here to help you make informed investment decisions today.

FIND US ON

Receive our REGN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

REGN Stock trends

REGN Stock performance

REGN Stock analysis

REGN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

REGN Stock Analysis & IQ Rating | Regeneron Pharmaceuticals

REGN Stock IQ

REGN Target Price

REGN Risk Level

REGN Analysts Opinion

REGN Street Sentiment

REGN Performance Sentiment

Technical Price Levels

Explore our REGN Stock insights

Receive our REGN Daily Alerts

REGN Street Sentiment

REGN Risk Level

Technical Price Levels

Discover REGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of REGN. We're here to help you make informed investment decisions today.

Receive our REGN Daily Alerts

REGN Runner Alarm